IQVIA's integrated respiratory research solution combines electronic Clinical Outcome Assessments (eCOAs), connected respiratory devices, and therapeutic expertise to deliver a comprehensive view of patient health throughout asthma, COPD, and other lung disease clinical trials. The platform integrates patient-reported symptom data with objective measurements from spirometers, peak flow meters, and other respiratory devices to generate richer clinical evidence while reducing participant burden. Features such as home monitoring, BYOD support, standardized workflows, proactive data monitoring, and real-time quality review improve study efficiency, patient engagement, and regulatory readiness. Supported by IQVIA's Allergy & Respiratory Center of Excellence, the solution enables earlier detecti

Join for free to read